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Abstract
Background: Adipose tissue secreted proteins are collectively named adipocytokines and include
leptin, adiponectin, resistin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26)
and omentin. Several of these adipocytokines influence insulin sensitivity and glucose metabolism
and therefore systemic levels may be affected by oral glucose uptake. Whereas contradictory
results have been published for leptin and adiponectin, resistin has not been extensively investigated
and no reports on omentin and CORS-26 do exist.
Methods: Therefore the plasma levels of these proteins before and 120 min after an oral glucose
load were analyzed in 20 highly-insulin sensitive, young adults by ELISA or immunoblot.
Results: Circulating leptin was reduced 2 h after glucose uptake whereas adiponectin and resistin
levels are not changed. Distribution of adiponectin and CORS-26 isoforms were similar before and
after glucose ingestion. Omentin is highly abundant in plasma and immunoblot analysis revealed no
alterations when plasma levels before and 2 h after glucose intake were compared.
Conclusion: Taken together our data indicate that only leptin is reduced by glucose uptake in
insulin-sensitive probands whereas adiponectin and resistin are not altered. CORS-26 was
demonstrated for the first time to circulate as high molecular weight form in plasma and like
omentin was not influenced by oral glucose load. Omentin was shown to enhance insulin-stimulated
glucose uptake but systemic levels are not correlated to postprandial blood glucose.
Background
Several adipose tissue derived proteins have a major
impact on the regulation of energy homeostasis and there-
fore are in the focus of current research. Leptin, in the
hypothalamus, regulates food uptake and in addition has
numerous effects on peripheral cells and organs including
the regulation of immune cells, pancreatic beta cells, adi-
pocytes, and muscle and liver insulin sensitivity [1]. Adi-
pocytokines may also exert a metabolic role in
postprandial hyperglycemia and therefore, systemic leptin
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was investigated in several studies. Leptin concentrations
during oral glucose tolerance test (OGTT) in normal
weight women were found unchanged whereas in obese
women an increase [2,3] or no alterations have been
described [4]. In insulin-sensitive men, a reduction of lep-
tin was detected in lean and obese probands whereas in
the insulin-resistant state, leptin did not change [5].
While systemic leptin is increased in obesity, adiponectin
is reduced [6]. Adiponectin is known to exert anti-inflam-
matory and insulin-sensitizing effects but in addition,
proinflammatory activities have been described [6-8].
Adiponectin circulates in blood as trimers, hexamers, and
higher molecular weight (HMW) complexes [6] and
recent studies indicate that the HMW adiponectin is the
active form of the protein [9]. Total circulating adiponec-
tin was significantly increased in women with polycystic
ovary syndrome at 120 min of OGTT [10] whereas it was
not altered in normal glucose tolerant, impaired glucose
tolerant and type 2 diabetic probands 2 h after glucose
ingestion [11]. The adiponectin paralog CORS-26 (colla-
genous repeat-containing sequence of 26 kDa protein) is
produced in adipocytes and monocytes and has antiin-
flammatory properties [12]. Although in vitro data sug-
gest that CORS-26 is a secreted protein [12], CORS-26 in
human plasma has not been investigated so far.
Resistin, initially identified in mice as an adipose tissue
derived protein, has been associated with the low grade
inflammation and insulin resistance in type 2 diabetic
patients [13]. Although in rodents resistin cleary disturbs
glucose and lipid homeostasis, its role in humans is
unclear [14]. So far no association of circulating resistin
and glucose homeostasis has been identified and healthy
controls even had significantly higher systemic resistin
levels than patients with type 1 and type 2 diabetes [15].
Systemic resistin was determined after oral glucose load
and was not significantly altered during OGTT [10].
Omentin is highly abundant in the stroma vascular frac-
tion of visceral fat and was detected in human serum by
immunoblot [16]. Recombinant omentin enhances insu-
lin-stimulated glucose uptake in adipocytes [16] but so far
it was not analyzed whether systemic omentin is affected
by acute hyperglycemia.
The adipose tissue secreted proteins described above were
investigated in 20 young, insulin-sensitive probands after
an overnight fast and 2 h following glucose uptake. The
data obtained may help to further clarify the physiological
regulation of well described plasma proteins like leptin
and adiponectin but in addition reveal new insights on
the abundance of resistin, omentin and CORS-26 in the
plasma of young adults before and after glucose uptake.
Methods
Subjects
Twenty healthy subjects (6 females and fourteen males,
weight range: 55–86 kg, mean BMI 22.5 ± 2 kg/m2, mean
age 22.2 ± 0.5 years) participated in the study. A baseline
blood sample was taken after overnight fasting. They were
given 75 g glucose dissolved in 300 ml water and a second
blood sample was taken 2 h later. The study protocol was
approved by the local ethics committee and was carried
out in accordance with the Helsinki guidelines. All
probands gave written informed consent to participate in
the study.
Reagents
DuoSet ELISA Development System for human resistin,
leptin and adiponectin as well as CORS-26 and adiponec-
tin antibodies were purchased from R&D Systems (Wies-
baden-Nordenstadt, Germany). Insulin ELISA was from
Mercodia (Uppsala, Sweden). Omentin antibody was
raised in rabbits with the use of a peptide (IYQKYPVKY-
GEGKC) for immunization.
SDS-PAGE and immunoblotting
The plasma was diluted 1:1,000 in PBS for the detection
of adiponectin, 1:200 for CORS-26 and 1:50 for omentin
immunoblots. Proteins were separated by SDS-polyacry-
lamide gel electrophoresis and were transferred to PVDF
membranes. Incubations with antibodies were performed
in 5% nonfat dry milk in PBS, 0.1% Tween. Detection of
the immune complexes was carried out with the ECL
Western blot detection system (Amersham Pharmacia,
Deisenhofen, Germany).
In-vitro translation of omentin
Full-length human omentin (Genbank acc. no.
CB266342) was amplified with the primers omentin_uni:
5'-atgaaccaactcagcttcctgct-3' and omentin_rev: 5'-acgata-
gaatagaagcacagca-3' from human adipose tissue mRNA
and was cloned into the expression vector pcDNA3.1/V5-
His(C) TOPO TA(R) (Invitrogen, Karlsruhe, Germany) and
sequenced. In-vitro translation was performed with the
TNT® T7 Quick Coupled Transcription/Translation System
(Promega, Mannheim, Germany).
ELISA
The ELISAs were performed as recommended by the dis-
tributor.
Statistics
Data are presented as mean ± standard deviation (SPSS
12.0 for Windows). Statistical differences were analyzed
by paired, two-tailed Student's t test and a value of p <
0.05 was regarded as statistically significant.Cardiovascular Diabetology 2007, 6:7 http://www.cardiab.com/content/6/1/7
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Results
Oral glucose tolerance test (OGTT)
Twenty healthy subjects participated in the study and
blood glucose in the fasted state was 88 ± 7 mg/dl (refer-
ence value 70 to 110 mg/dl) and 2 h after the glucose chal-
lenge 79 ± 14 mg/dl (reference value: less than 140 mg/
dl). Insulin was 2.4 ± 1 mU/l before and 7.4 ± 3.7 mU/l 2
h after oral glucose intake. The Homeostasis Model
Assessment (HOMA) Index was 0.5 ± 0.2 (reference value
< 1) indicating a high insulin sensitivity of the probands
who participated in the current study.
Determination of plasma leptin and adiponectin
Leptin was determined in the plasma of the 20 probands
in the fasted state and was 3.0 ± 2.8 ng/ml and 2 h after
glucose challenge it reached levels of 2.5 ± 2.5 ng/ml (p =
0.0003) (Figure 1A). Leptin in females in the fasted state
was 6.7 ± 2.1 ng/ml, and 2 h after glucose challenge it was
5.7 ± 1.9 ng/ml (p = 0.0006). In males 1.3 ± 0.5 ng/ml
were detected in the morning and 1.1 ± 0.6 ng/ml (p =
0.0005) postprandial. Leptin is higher abundant in
women and this was confirmed in our study group (p <
0.0001).
Adiponectin was significantly higher in females with 21.3
± 11.8 µg/ml when compared to males with 10.1 ± 3.4 µg/
ml. In the fasted state, adiponectin was 13.5 ± 8.5 µg/ml
and 13.1 ± 6.7 µg/ml 2 h after glucose uptake (p = 0.27)
when the plasma of all donors was compared. Similar
results were obtained when men and women were ana-
lyzed separately (not shown). Besides total circulating adi-
ponectin, the levels of the HMW adiponectin isoforms
were analyzed by immunoblot. Plasma samples were sep-
arated by SDS-PAGE under non-reducing conditions and
HMW-APM was detected in all plasma samples (Figure
1B). Reducing conditions convert the HMW-APM to a
protein subunit of about 75 kDa most likely resembling
trimeric APM and similar amounts were detected in the
plasma before and after glucose ingestion (Figure 1B).
Determination of plasma resistin
Resistin was 1.77 ± 0.57 ng/ml before and 1.77 ± 0.59 ng/
ml after glucose challenge (p = 0.47) and similar data were
obtained when resistin plasma samples from men and
women were calculated separately (not shown).
Analysis of CORS-26 by immunoblot
Specificity of the CORS-26 antibody was analyzed by
immunoblot using recombinant adiponectin and recom-
binant CORS-26 produced in insect cells [7,12]. 100 ng of
protein was separated by SDS-PAGE and silver staining of
the gel revealed similar amounts of protein (Figure 2A).
Leptin and adiponectin in fasting plasma and plasma after glucose challenge Figure 1
Leptin and adiponectin in fasting plasma and plasma after glucose challenge. (A) Leptin was determined in the 
plasma of 20 probands after an overnight fast and 2 h after glucose uptake by ELISA (B) Adiponectin was analyzed by non-dena-
turing SDS-PAGE (high-molecular weight, HMW) and denaturing SDS-PAGE (low-molecular weight, LMW) and a representa-
tive result after fasting (0) and 2 h (2) after glucose uptake is shown for probands 1 to 4. The molecular mass of standard 
proteins in kDa is indicated on the left side of the immunoblot.Cardiovascular Diabetology 2007, 6:7 http://www.cardiab.com/content/6/1/7
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The membranes were hybridized with adiponectin or
CORS-26 antibody and each antiserum revealed a specific
signal with the respective protein (Figure 2A).
Plasma of the 20 probands was analyzed by immunoblot
using the CORS-26 antibody and CORS-26 was found
highly abundant. Quantification of the immunoblots
using OptiQuant software revealed a 2-fold difference in
CORS-26 plasma levels when all samples were compared
(not shown).
CORS-26 was similarly abundant before and after glucose
uptake but immunoblot is not suitable to detect changes
of less than 20% in protein levels and therefore alteration
below 20% can not be excluded (Figure 2B). Plasma sam-
ples were separated by SDS-PAGE under non-reducing
conditions and CORS-26 was detected in all plasma sam-
ples as a high molecular weight complex of about 180 to
250 kDa (Figure 2B). Reducing conditions convert the
HMW-CORS-26 to a protein subunit of about 60 kDa that
may resemble monomeric or dimeric protein and similar
amounts were detected in the plasma before and after glu-
cose ingestion (Figure 2B).
Analysis of omentin by immunoblot
In vitro translated omentin and a control protein with a C-
terminal V5 tag were used for immunoblot using an anti-
V5 antibody (not shown) or anti-omentin antibody (Fig-
ure 3A). Anti-omentin antibody specifically detects omen-
tin protein and therefore was used for immunoblots.
Plasma before and after glucose uptake was analyzed and
omentin with a molecular weight of 30 kDa was found
similar abundant and a representative result is shown in
figure 3B. Serial dilution of plasma revealed that a differ-
ence of 20 % can be detected by immunoblot and the sub-
sequent quantification of the signals with OptiQuant
software (not shown).
A high variability of omentin plasma levels was identified
when plasma of different donors was compared and
quantification of the immunoblot using OptiQuant soft-
ware revealed an up to 5.8-fold difference. However, these
variations were not related to the gender of the plasma
donors (Figure 3C). Pearson correlation did not identify a
correlation of plasma omentin levels with fasting or post-
prandial blood glucose or changes in blood glucose when
fasting values and values 2 h after glucose ingestion were
calculated (not shown).
Discussion
Adipose tissue secretes a variety of molecules into the cir-
culation. These adipocyte-derived proteins are involved in
the maintenance of energy homeostasis, insulin action,
glucose and lipid metabolism and therefore sytemic levels
Specificity of the CORS-26 antiserum and CORS-26 in fasting plasma and plasma after glucose challenge Figure 2
Specificity of the CORS-26 antiserum and CORS-26 in fasting plasma and plasma after glucose challenge. (A) 
Recombinant adiponectin (Apm) and CORS-26 on a silver-stained SDS-PAGE gel and upon detection by the respective anti-
bodies using immunoblot. (B) High-molecular weight (HMW) CORS-26 was analyzed by non-denaturing SDS-PAGE and low-
molecular weight (LMW) CORS-26 by denaturing SDS-PAGE and a representative result of 4 donors (1 to 4) after fasting (0) 
and 2 h (2) after glucose uptake is shown. The molecular mass of standard proteins in kDa is indicated on the left side of the 
immunoblot.Cardiovascular Diabetology 2007, 6:7 http://www.cardiab.com/content/6/1/7
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were analyzed before and 2 h after glucose uptake.
Because most studies focus on overweight probands or
patients that may not reflect the normal situation, plasma
levels of several adipose tissue secreted proteins were ana-
lyzed in the fasted state and 2 h after the ingestion of 75 g
glucose in young, slim and highly insulin-sensitive adults.
In contrast to some studies that describe an induction or
no alterations of leptin [2-4], systemic leptin was found
reduced 2 h after glucose ingestion to 85 ± 8% in our
study group and this is in accordance with the findings of
Masuo et al. [5], where insulin-sensitive probands also
showed lower leptin levels. Leptin did not change in insu-
lin-resistant subjects in their study [5] indicating an
altered response of systemic leptin in insulin-resistant
probands. Leptin is suggested to increase insulin sensitiv-
ity or to cause insulin resistance [17] and obesity is asso-
ciated with leptin resistance and a decreased transport of
leptin across the blood-brain barrier [18]. Leptin appears
to exert its function mainly in the hypothalamus. Leptin
increases serotonin turnover by inhibition of nitric oxide
(NO) synthesis in the brain and endogenous hypotha-
lamic serotonin (5-hydroxytryptamine) is well described
to control appetite and caloric intake [19]. Injection of
leptin into the ventromedial hypothalamus increases glu-
cose uptake and decreases hepatic glycogen without any
alterations of plasma insulin or glucose levels suggesting
that peripheral effects of leptin on glucose metabolism are
mediated by the central nervous system [20]. Bradykinin
and NO were identified to be involved in leptin-mediated
glucose uptake in skeletal muscle [21].
Leptin is not suggested to regulate short-term food intake
and central administration of leptin in monkeys reduced
food intake the following day [22]. Therefore reduced cir-
culating leptin after carbohydrate ingestion may be an
important factor in controlling body weight in slim
adults.
In contrast to leptin, adiponectin and resistin were not
altered 2 h after glucose uptake and this is in agreement
with recent studies [10,11] indicating that systemic adi-
ponectin and resistin are not influenced upon acute
hyperglycemia and/or hyperinsulinemia. Adiponectin
enhances insulin signaling by reducing p70 S6 kinase-
mediated serine phosphorylation of IRS-1 [23] but sys-
Specificity of the omentin antiserum and omentin in fasting plasma and plasma after glucose challenge Figure 3
Specificity of the omentin antiserum and omentin in fasting plasma and plasma after glucose challenge. (A) In 
vitro translated omentin and a control protein were used to determine the specificity of the omentin antiserum. (B) Omentin 
was analyzed in the plasma of all probands and a representative result of the probands 1 to 4 after an overnight fast (0) and 2 h 
(2) after glucose uptake by immunoblot is shown. (C) Omentin in the plasma of women (F9, F10, F12, F17) and men (M4, M8, 
M11, M13, M14, M15, M18, M19, M20) was determined by immunoblot.Cardiovascular Diabetology 2007, 6:7 http://www.cardiab.com/content/6/1/7
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temic adiponectin levels are not influenced by carbohy-
drate uptake. The mRNA expression of the adiponectin
receptors AdipoR1 and AdipoR2 is reduced by refeeding
in mice and by insulin in-vitro indicating that adiponectin
effects are regulated at the receptor level in the postpran-
dial phase [24]. Resistin is regarded as a proinflammatory
protein and was recently shown to block insulin signaling
in human hepatocytes [25] but al least systemic resistin is
not influenced by glucose uptake in insulin-sensitive
probands.
The adiponectin paralog CORS-26 was shown to be
highly abundant in human plasma for the first time
whereas it was not detected in mouse serum [26]. Further-
more, similar to adiponectin, CORS-26 circulates as a
HMW complex that is converted to a lower molecular
weight form by denaturating conditions. Systemic CORS-
26 was similar before and after glucose uptake although
immunoblot analysis may only be suitable to detect
changes of at least 20% and a suitable ELISA is needed to
further investigate systemic CORS-26. So far the physio-
logical role of CORS-26 is unclear. E. coli produced CORS-
26 stimulates the proliferation of chondrogenic precur-
sors and chondrocytes thereby regulating chondrogenesis
and cartilage development [27]. In contrast to adiponec-
tin that is only synthesized by adipocytes, CORS-26 is also
expressed in kidney cells and monocytes [12]. Neverthe-
less CORS-26 may exert similar functions as adiponectin,
and antiinflammatory effects [12] and the formation of
HMW complexes, by both proteins further supports this
hypothesis. Therefore the effect of recombinant CORS-26
on insulin signaling has to be investigated to further eval-
uate the physiological role of this protein.
Omentin, initially identified as intelectin-1 expressed in
intestinal paneth cells [28,29], is highly abundant in the
stroma vascular fraction of omental adipose tissue [16].
Omentin was detected in the sera of three donors and the
concentration was determined to be 100 ng to 1 µg/ml
[16]. This protein recognizes galactofuranose and plays a
role in the recognition of bacteria-specific components in
the host [30]. In the current study omentin was easily
detected in plasma by immunoblot but levels were not
markedly influenced upon glucose uptake nor related to
the gender of the donor. Omentin enhances insulin-stim-
ulated glucose uptake in subcutaneous and visceral
human adipocytes in-vitro [16] and therefore systemic
omentin may influence postprandial glucose levels. How-
ever, systemic omentin levels did not correlate to post-
prandial blood glucose indicating that at least circulating
omentin is not directly associated with postprandial glu-
cose levels in vivo.
Conclusion
Postprandial hyperglycemia is associated with lower cir-
culating leptin whereas resistin and adiponectin are not
altered in slim, insulin-sensitive probands. CORS-26 and
omentin are highly abundant in human plasma and are
not severely affected by glucose uptake, although this has
to be confirmed with a more quantitative method. Future
studies will have to further elucidate the biological rele-
vance of these adipocytokines in glucose homeostasis.
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